AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹12,480 Cr | ₹11,573 Cr | ₹9,966 Cr | ₹9,888 Cr | ₹9,075 Cr |
What is the latest Net Current Assets ratio of AUROBINDO PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹12,480 Cr |
| Mar2024 | ₹11,573 Cr |
| Mar2023 | ₹9,966 Cr |
| Mar2022 | ₹9,888 Cr |
| Mar2021 | ₹9,075 Cr |
How is Net Current Assets of AUROBINDO PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹12,480 Cr | 7.84 | |
| Mar2024 | ₹11,573 Cr | 16.12 | |
| Mar2023 | ₹9,966 Cr | 0.79 | |
| Mar2022 | ₹9,888 Cr | 8.96 | |
| Mar2021 | ₹9,075 Cr | - | |
Compare Net Current Assets of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹70,271.0 Cr | 1.4% | -1.9% | -4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,768.0 Cr | -2.7% | -2.2% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,385.0 Cr | -0.7% | -1.1% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,242.0 Cr | -0.8% | 0.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,093.0 Cr | -1.2% | -1.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,799.0 Cr | NA | 2.4% | 0.2% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 1.4% |
-1.9% |
-4.2% |
| SENSEX | -0.4% |
-0.2% |
2.9% |
You may also like the below Video Courses